Clinical Trials
20 trialsNCT04924413 2024-07-03
L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma
Henan Cancer Hospital
Phase 2 Terminated
NCT02621333 2021-05-12
Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma
Henan Cancer Hospital
Phase 2 Terminated
NCT03170115 2020-12-17
ICAR
Instituto Nacional de Cancer, Brazil
Phase 2 Terminated
NCT03002831 2020-04-02
Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer
Henan Cancer Hospital
Phase 2 Terminated
NCT02950103 2019-09-30
Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients
Secretaria de Estado da Saúde
Phase 2 Terminated
NCT02626754 2018-06-26
A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population
Taipei Veterans General Hospital, Taiwan
Phase 2 Terminated
NCT03161548 2017-05-30
A Study of Tongue Conservation Surgery for Oral Tongue Cancer
Taipei Veterans General Hospital, Taiwan
Phase 2 Terminated
NCT01405846 2016-08-19
TIDAL1
Papworth Hospital NHS Foundation Trust
Phase 2 Terminated
NCT01159327 2015-11-11
Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy
National Cancer Center, Korea
Phase 2 Terminated
NCT00128362 2014-06-24
Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer
Tata Memorial Hospital
Phase 2 Terminated
NCT00636883 2014-01-22
GEMOX-T
National Guard Health Affairs
Phase 2 Terminated
NCT01356368 2014-01-22
Customizing
National Guard Health Affairs
Phase 2 Terminated
NCT00412919 2013-12-16
Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma
Bayside Health
Phase 2 Terminated
NCT01412515 2012-01-02
A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma
Institut National de la Santé Et de la Recherche Médicale, France
Phase 2 Terminated
NCT00532285 2011-06-23
Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
National Cancer Center, Korea
Phase 2 Terminated
NCT00532454 2010-02-10
Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen
National Cancer Center, Korea
Phase 2 Terminated
NCT00506168 2007-07-25
Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer
National Cancer Center, Korea
Phase 2 Terminated
NCT00127569 2007-01-12
Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
French National Agency for Research on AIDS and Viral Hepatitis
Phase 2 Terminated
NCT00395655 2006-11-03
Hydralazine and Valproate Added to Chemotherapy for Breast Cancer
National Institute of Cancerología
Phase 2 Terminated
NCT00126243 2005-08-17
Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma
French National Agency for Research on AIDS and Viral Hepatitis
Phase 2 Terminated